Stay updated on Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record for the imsidolimab study is displayed, with its study design, participant criteria, outcomes, locations, and supporting documents. This replaces a page that previously showed a 403 error.SummaryDifference61%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence.” The site revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record and showing the site's standard error layout.SummaryDifference17%

- Check60 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a backend/software update to the page rendering.SummaryDifference0.0%

Stay in the know with updates to Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.